FDA Investigator Kimberly Jproctor Jones
Kimberly Jproctor Jones has conducted inspections on 112 sites in 3 countries as of 18 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
112
Last Inspection Date:
18 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Mexico,
United States of America,
Indonesia
FDA Investigators that have inspected at least one site in common with Kimberly Jproctor Jones:
Aaron J Poloni,
Abby M Miller,
Alan D Grupe,
Alicia M Weitzel,
Amber M Howell,
Amy R Glynn,
Andrew K Haack, PhD,
Anh Trinh T Nguyen,
Ashleigh P Barkans,
Astrida B Mattson,
Ava M Bowman,
Avery J Dennis,
Barbara J Rincon,
Belinda E Clifton,
Bradley E Tufto,
Brenda K Alford,
Brenda L Reihing,
Brian P Hendrickson,
Bruce R Burrell,
Bryce E Mansfield,
Camille Bennett Hoffman,
Catherine J Laufmann,
Ce'nedra M Martin,
Christopher R Czajka,
Christopher S Genther,
Clara E Santiago,
Colleen M Jones,
Connie P Rezendes,
Crystal A Harlan,
Cynthia L Gorveatt,
Dan C Fisher,
Daniel A Congdon,
Dariusz Galezowski,
David A Quale,
David J Gomes,
David L Hunsaker,
David P King,
Dawn E Barkans,
Deborah A Nebenzahl,
Debra D Devlieger,
Dennis R Hudson,
Devon M Shoop,
Dianne B Latona,
Dirk L Lincoln,
Don A Brunssen,
Donald B Mckechnie,
Donald W Jehn,
Elizabeth A Sheller,
Elizabeth S Howell,
Eric C Andes,
Eric L Scott,
Erica R Mahone,
Gavin W Pierce,
Gerard Pde Leon,
Gordon T Wales,
Harmon M Blanch,
Heika R Tait,
Hugh A Grimoldby,
Hughes,
Ian J Thomson,
Isaiah D Isakson,
James E Trabert,
James S Cartwright,
Jane M Kreis,
Janete A Oliveira,
Jason T Lovelady,
Jean Brewer,
Jean C Colon Lopez,
Jean R Mccurry,
Jeanne M Weishaar,
Jeff A Gard,
Jeffrey J Leclair,
Jeffrey N Gerdes,
Jennifer W Cheng Dobson,
Jessica B Clark,
Jessica L Kocian,
Jessie J Deloach,
Jinkee Mvila Binayug,
John A Hall,
John E Emmert,
John W Banks,
Jonathan R Ormond,
Jonathan T Little,
Joseph A Seitz, III,
Joseph M Hudak,
Julia E Chervoni,
Katharine Chan,
Katherine L Arnold,
Keegan B Mixon,
Keishla M Arroyo Lopez,
Kelsey A Hustedt,
Kelsey A Volkman,
Kelsey M Bishop,
Kenneth O Gee, PhD,
Kevin T Gerrity,
Kristina M Phelps,
Lance W Bohm,
Lauren E Swantko,
Lenita R Silvera,
Leon R Marquart,
Lesley A Swanson,
Lester O Boian,
Leya A Grosch,
Lisa A Bowden,
Lisa K Capron,
Lori J Jennings,
Lori J Silverstein,
Lynda L Perry, PhD,
Marc Balzarini,
Margo C Jones,
Maria Pkelly Doggett, MBA,
Marijo B Kambere, PhD,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Mark S Crippen,
Marsha L Mccauley,
Matthew R Barr,
Michael F Schuette,
Michael J Donovan,
Michael S Hudson,
Michael S Valenzuela,
Mikel T Wright,
Misty L Wallace,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Ngoc Lan T Nguyen,
Orval D Mcintire,
Paul F Rader,
Paul M Kawamoto,
Paula J Wilkerson,
Peter Kessler, PhD,
Peter T Regan,
Philip E Ake,
Phillip J Dugger,
Rachel J Cantrell,
Rachelle M Deskins,
Rebecca A Sletner,
Rebecca T Davis,
Richard A Martin,
Richard F Hapke,
Richard G Runyon,
Rita E Luttrell,
Robert A Williams,
Robert F Hennes,
Rocco C Black,
Roger F Zabinski,
Roger J Adams,
Ronald E Gill,
S Lori Brown, PhD MPH,
Sandra K Wangen,
Sangeeta M Khurana, PhD,
Scott W Fox,
Shahriar Rahmani,
Shannon J Hall,
Sharon I Gundersen,
Sharon K Ferguson,
Shelagh D Schopen,
Sonia R Peterson,
Stacie A Woods,
Stephanie A Jameson,
Stephanie A Slater, MS,
Stephanie J Shaw,
Stephen R Souza,
Steven L Robbs,
Sunitha K Rajaram, PhD,
Sunny R Muir,
Tara A Marshall,
Tara M Pianko,
Thomas C Mclean, CFS,
Timothy E Sample,
Timothy S Williamson,
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vitaliy N Guyvan,
Wayne D Stowell,
Wilfred J Omoloh,
William A Burkey,
William C Hughes,
Willis L Hicks,
Xiaojun Yan,
Young M Yoon,
Zachary P Wachlarowicz
Kimberly Jproctor Jones's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2017 | FDA 483 | Herbal Junction - Form 483, 2017-07-05 |
July, 2015 | FDA 483 | Greenland Inc. - Form 483, 2015-07-06 |
November, 2013 | EIR | Johnson Foods, Inc. - EIR, 2016-10-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more